A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
Public ClinicalTrials.gov record NCT04418765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study With an Extension Period to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Patients With Unsuccessful Prior Preventive Treatments
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Evaluation of eptinezumab in the prevention of migraine in participants with unsuccessful prior preventive treatments.
Study identification
- NCT ID
- NCT04418765
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 892 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2020
- Primary completion
- Jul 14, 2021
- Completion
- Sep 14, 2022
- Last update posted
- Sep 28, 2023
2020 – 2022
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Sarkis Clinical Trials - Gainesville | Gainesville | Florida | 32607 | — |
| Accel Research Sites - Maitland | Maitland | Florida | 32751 | — |
| Michigan Headache and Neurological Institute | Ann Arbor | Michigan | 48104-5131 | — |
| Clinical Research Institute Inc. - Minneapolis | Minneapolis | Minnesota | 55402 | — |
| Albuqerque Clinical Trials | Albuquerque | New Mexico | 87102 | — |
| Dent Neurologic Institute - Amherst | Amherst | New York | 14226 | — |
| Integrative Clinical Trials | Brooklyn | New York | 11229 | — |
| CTI Clinical Research Center | Cincinnati | Ohio | 45212 | — |
| Hometown Urgent Care & Occupational Health/Hometown Research - Huber Heights | Dayton | Ohio | 45424 | — |
| Lynn Health Science Institute - Oklahoma City | Oklahoma City | Oklahoma | 73112 | — |
| Clinical Neuroscience Solutions - Memphis | Memphis | Tennessee | 38119 | — |
| Northwest Clinical Research Center (NWCRC) | Bellevue | Washington | 98007 | — |
| Northwest Neurological | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 124 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04418765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2023 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04418765 live on ClinicalTrials.gov.